66 related articles for article (PubMed ID: 23649842)
41. Organic anion transporter 5 renal expression and urinary excretion in rats with vascular calcification.
Hazelhoff MH; Bulacio RP; Torres AM
Biomed Res Int; 2013; 2013():283429. PubMed ID: 24199190
[TBL] [Abstract][Full Text] [Related]
42. The urinary excretion of an organic anion transporter as an early biomarker of methotrexate-induced kidney injury.
Severin MJ; Trebucobich MS; Buszniez P; Brandoni A; Torres AM
Toxicol Res (Camb); 2016 Mar; 5(2):530-538. PubMed ID: 30090367
[TBL] [Abstract][Full Text] [Related]
43. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of Cisplatin nephrotoxicity.
Miller RP; Tadagavadi RK; Ramesh G; Reeves WB
Toxins (Basel); 2010 Nov; 2(11):2490-518. PubMed ID: 22069563
[TBL] [Abstract][Full Text] [Related]
45. Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapy.
George B; Wen X; Mercke N; Gomez M; O'Bryant C; Bowles DW; Hu Y; Hogan SL; Joy MS; Aleksunes LM
Toxicol Rep; 2020; 7():571-576. PubMed ID: 32382514
[TBL] [Abstract][Full Text] [Related]
46. Sulforaphane exhibits potent renoprotective effects in preclinical models of kidney diseases: A systematic review and meta-analysis.
Monteiro EB; Ajackson M; Stockler-Pinto MB; Guebre-Egziabher F; Daleprane JB; Soulage CO
Life Sci; 2023 Jun; 322():121664. PubMed ID: 37023957
[TBL] [Abstract][Full Text] [Related]
47. Anticancer drug-induced kidney disorders.
Kintzel PE
Drug Saf; 2001 Jan; 24(1):19-38. PubMed ID: 11219485
[TBL] [Abstract][Full Text] [Related]
48. Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury.
Noiri E; Doi K; Negishi K; Tanaka T; Hamasaki Y; Fujita T; Portilla D; Sugaya T
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F669-79. PubMed ID: 19019918
[TBL] [Abstract][Full Text] [Related]
49. Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase.
Hümmeke-Oppers F; Hemelaar P; Pickkers P
Front Pharmacol; 2019; 10():919. PubMed ID: 31507417
[TBL] [Abstract][Full Text] [Related]
50. Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.
Selim MS; Kassem AB; El-Bassiouny NA; Salahuddin A; Abu El-Ela RY; Hamza MS
Med Oncol; 2023 Jan; 40(2):80. PubMed ID: 36650399
[TBL] [Abstract][Full Text] [Related]
51. Urinary Peptidomic Biomarkers in Kidney Diseases.
Sirolli V; Pieroni L; Di Liberato L; Urbani A; Bonomini M
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877774
[TBL] [Abstract][Full Text] [Related]
52. Prevention of Chemotherapy-Induced Nephrotoxicity in Children with Cancer.
Sharbaf FG; Farhangi H; Assadi F
Int J Prev Med; 2017; 8():76. PubMed ID: 29114374
[TBL] [Abstract][Full Text] [Related]
53. Cisplatin-induced renal toxicity in elderly people.
Duan Z; Cai G; Li J; Chen X
Ther Adv Med Oncol; 2020; 12():1758835920923430. PubMed ID: 32489432
[TBL] [Abstract][Full Text] [Related]
54. Metabolomics as an extension of proteomic analysis: study of acute kidney injury.
Portilla D; Schnackenberg L; Beger RD
Semin Nephrol; 2007 Nov; 27(6):609-20. PubMed ID: 18061843
[TBL] [Abstract][Full Text] [Related]
55. Pharmacology behind Common Drug Nephrotoxicities.
Perazella MA
Clin J Am Soc Nephrol; 2018 Dec; 13(12):1897-1908. PubMed ID: 29622670
[TBL] [Abstract][Full Text] [Related]
56. The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant?
Bramham K; Mistry HD; Poston L; Chappell LC; Thompson AJ
QJM; 2009 Aug; 102(8):523-38. PubMed ID: 19553250
[TBL] [Abstract][Full Text] [Related]
57. Drug induced nephrotoxicity- A mechanistic approach.
Sharma V; Singh TG
Mol Biol Rep; 2023 Aug; 50(8):6975-6986. PubMed ID: 37378746
[TBL] [Abstract][Full Text] [Related]
58. Urinary exosomes: a promising biomarker of drug-induced nephrotoxicity.
Zhou Z; Zhang D; Wang Y; Liu C; Wang L; Yuan Y; Xu X; Jiang Y
Front Med (Lausanne); 2023; 10():1251839. PubMed ID: 37809338
[TBL] [Abstract][Full Text] [Related]
59. Importance of urinary mitochondrial DNA in diagnosis and prognosis of kidney diseases.
Zhang M; Zhang Y; Wu M; Li Z; Li X; Liu Z; Hu W; Liu H; Li X
Mitochondrion; 2021 Nov; 61():174-178. PubMed ID: 34673260
[TBL] [Abstract][Full Text] [Related]
60. The renal damage and mechanisms relevant to antitumoral drugs.
Tang J; Yang N; Pan S; Ren P; Chen M; Jin J; He Q; Zeng Y
Front Oncol; 2023; 13():1331671. PubMed ID: 38148845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
